IIUM Repository

Dr Fazia Adyani Ahmad Fuad

Profile Picture

Latest Additions

  1. Che Abdul Aziz, Faqihah Izzati and Ahmad Fuad, Fazia Adyani and Tanbin, Suriyea (2021) Virtual Screening and In Silico Interactions Studies for Potential Antivirals and Diagnostics against the Spike protein from the Novel Coronavirus SARS-Cov-2. In: 6th International Conference on Biotechnology Engineering (ICBioE 2021), Kuala Lumpur (Virtual).
  2. Ogu Salim, Nurhainis and Ahmad Fuad, Fazia Adyani and Khairuddin, Farahayu and Wan Seman, Wan Mohd Khairulikhsan and Jonet, Mohd Anuar (2021) Purifying and characterizing bacterially expressed soluble Lactate Dehydrogenase from Plasmodium knowlesi for the development of anti-malarial drugs. Molecules, 26 (21). E-ISSN 1420-3049
  3. Ahmad Fuad, Fazia Adyani and Tanbin, Suriyea (2021) Enhanced expression and purification strategy for recombinant bacterially-expressed human hexokinase II. Molekul, 16 (1). pp. 82-91. ISSN 1907-9761 E-ISSN 2503-0310
  4. Ahmad Fuad, Fazia Adyani and Tanbin, Suriyea (2020) Interrogating novel compounds for improved anti-dengue therapies via inhibition of human hexokinase II (HKII). In: Nanotechnology Symposium 2020, 21st Feb. 2020, Kuala Lumpur, Malaysia. (Unpublished)
  5. Tanbin, Suriyea and Ahmad Fuad, Fazia Adyani (2020) Novel compounds as potential anti-dengue therapies verified via inhibition of human hexokinase isoform II. In: Kulliyyah of Engineering Research, Innovation and Commercialization Exhibition 2020 (KERICE '20), 8th Dec. 2020, Virtual Platform. (Unpublished)
  6. Tanbin, Suriyea and Mohd Razali, Nur Izzati and Ahmad Fuad, Fazia Adyani (2019) Elucidating the analogues of 3-bromopyruvate (3-BP) as inhibitors against human hexokinase II for the development of anti-dengue drugs. In: 8th International Molecular Biology And Biotechnology Congress (MOLBIOTECH), 17 - 20 Dec 2019, Uskudar, Turkey.
  7. Tanbin, Suriyea and Ahmad Fuad, Fazia Adyani and Abdul Hamid, Azzmer Azzar (2021) Virtual screening for potential inhibitors of human hexokinase II for the development of anti-dengue therapeutics. BioTech, 10 (1). pp. 1-28. ISSN 2673-6284
  8. Ahmad Fuad, Fazia Adyani and Abdul Hamid, Azzmer Azzar and Tanbin, Suriyea (2020) Virtual screening for potential inhibitors of human hexoki-nase ii for the development of anti-dengue therapeutics. MDPI Biotech. ISSN 2673-6284 (In Press)
  9. Asman, Nur Atikah and Tanbin, Suriyea and Ahmad Fuad, Fazia Adyani (2020) Effects off Daidzin and analogue off ganoderma sinensetin bacterially-expressed human hexokinase isofform 2 for anti-dengue drug design. Biological And Natural Resources Engineering Journal, 3 (2). pp. 27-34. E-ISSN 2637-0719
  10. Ahammad, Foysal and Tengku Abd Rashid, Tengku Rogayah and Mohamed, Maizan and Tanbin, Suriyea and Ahmad Fuad, Fazia Adyani (2019) Contemporary strategies and current trends in designing antiviral drugs against dengue fever via targeting host-based approaches. Microorganisms, 7 (9). pp. 1-28. ISSN 2076-2607
  11. Ogu Salim, Nurhainis and Md Yusuf, Noor Azian and Ahmad Fuad, Fazia Adyani (2019) Plasmodial enzymes in metabolic pathways as therapeutic targets and contemporary strategies to discover new antimalarial drugs: a review. Asia-Pacific Journal of Molecular Biology and Biotechnology, 27 (4). pp. 38-53. E-ISSN 0128-7451
  12. Tanbin, Suriyea and Ahmad Fuad, Fazia Adyani (2019) Expression and purification of soluble bacterially-expressed human hexokinase II in E.coli system. In: "9th International Conference on Biomedical Engineering and Technology, ICBET 2019", 28 - 30 Mar 2019, Meiji UniversityTokyo, Japan.
  13. Tanbin, Suriyea and Ogu Salim, Nurhainis and Ahmad Fuad, Fazia Adyani (2019) Identifying analogues of 2-deoxyglucose, alpha-d-glucose and beta-d-glucose-6-phosphate as potential inhibitors of human hexokinase ii for the development of anti-dengue therapeutics. Pertanika Journal of Science and Technology, 27 (4). pp. 1625-1647. ISSN 0128-7680
  14. Tanbin, Suriyea and Ogu Salim, Nurhainis and Ahmad Fuad, Fazia Adyani (2018) Analogues of 2-Deoxyglucose as inhibitor candidates for hexokinase II identified via virtual screening analyses. In: 5th International Conference on Biotechnology Engineering (ICBioE 2018), 19th-20th September 2018, Kuala Lumpur.
  15. Ahmad Fuad, Fazia Adyani (2018) Characterization of conformational and oligomeric states of proteins. In: Multifaceted protocol in biotechnology. Springer Nature Singapore, pp. 167-178. ISBN 978-981-13-2256-3
  16. Ahmad Fuad, Fazia Adyani and Abdul Hamid, Azzmer Azzar and Saadun, Rafidah (2017) Identifying potential inhibitors of human hexokinase II for the development of anti-dengue therapeutics via virtual screening approaches. In: 4th Asian Regional Conference on Systems Biology, 20-22 Nov 2017, Putrajaya.
  17. Ahmad Fuad, Fazia Adyani and Ogu Salim, Nurhainis (2017) Screening potential inhibitors of lactate dehydrogenase from Plasmodium knowlesi via virtual screening approaches. Tropical Biomedicine, 34 (4). pp. 1-14. ISSN 0127-5720
  18. Ahmad Fuad, Fazia Adyani and Houston, Douglas Robert and Michels, Paul A M and Fothergill- Gilmore, Linda A. and Walkinshaw, Malcolm Douglas (2016) Inhibitors of leishmania mexicana phosphoglycerate mutase identified by virtual screening and verified by inhibition studies. Sains Malaysiana, 45 (7). pp. 1113-1120. ISSN 0126-6039
  19. Ahmad Fuad, Fazia Adyani (2013) Multiple oligomeric and conformational states of trypanosomatid phosphoglycerate mutases. In: 18th Lorne Proteomics Symposium 2013, 7th-10th Feb. 2013, Mantra Lorne, Victoria . (Unpublished)
  20. Ahmad Fuad, Fazia Adyani and Ismail, I and Sidik, N.M. and Zain , C.R.C.M. and Abdullah , R. (2008) Super binary vector system enhanced transformation frequency and expression level of polyhydroxyvalerate gene in oil palm immature embryo. Asian Journal of Plant Sciences, 7 (6). pp. 526-535. ISSN 1682-3974

Most Viewed Items

Item titleViews
1Trypanosomatid phosphoglycerate mutases have multiple conformational and oligomeric states1068
2Potential novel inhibitors of trypanosomatid phosphoglycerate mutases through ligand-based and structure-based in silico approaches1008
3Phosphoglycerate mutase from Trypanosoma brucei is hyperactivated by cobalt in vitro, but not in vivo963
4Multiple oligomeric and conformational states of trypanosomatid phosphoglycerate mutases941
5Inhibitors of leishmania mexicana phosphoglycerate mutase identified by virtual screening and verified by inhibition studies927
6Super binary vector system enhanced transformation frequency and expression level of polyhydroxyvalerate gene in oil palm immature embryo890
7Screening potential inhibitors of lactate dehydrogenase from Plasmodium knowlesi via virtual screening approaches744
8Identifying potential inhibitors of human hexokinase II for the development of anti-dengue therapeutics via virtual screening approaches742
9Characterization of conformational and oligomeric states of proteins606
10Analogues of 2-Deoxyglucose as inhibitor candidates for hexokinase II identified via virtual screening analyses385
11Identifying analogues of 2-deoxyglucose, alpha-d-glucose and beta-d-glucose-6-phosphate as potential inhibitors of human hexokinase ii for the development of anti-dengue therapeutics306
12Contemporary strategies and current trends in designing antiviral drugs against dengue fever via targeting host-based approaches301
13Plasmodial enzymes in metabolic pathways as therapeutic targets and contemporary strategies to discover new antimalarial drugs: a review282
14Expression and purification of soluble bacterially-expressed human hexokinase II in E.coli system250
15Virtual screening for potential inhibitors of human hexokinase II for the development of anti-dengue therapeutics189
16Virtual screening for potential inhibitors of human hexoki-nase ii for the development of anti-dengue therapeutics183
17Effects off Daidzin and analogue off ganoderma sinensetin bacterially-expressed human hexokinase isofform 2 for anti-dengue drug design176
18Elucidating the analogues of 3-bromopyruvate (3-BP) as inhibitors against human hexokinase II for the development of anti-dengue drugs148
19Novel compounds as potential anti-dengue therapies verified via inhibition of human hexokinase isoform II147
20Interrogating novel compounds for improved anti-dengue therapies via inhibition of human hexokinase II (HKII)141
21Enhanced expression and purification strategy for recombinant bacterially-expressed human hexokinase II105
22Purifying and characterizing bacterially expressed soluble Lactate Dehydrogenase from Plasmodium knowlesi for the development of anti-malarial drugs25
23Virtual Screening and In Silico Interactions Studies for Potential Antivirals and Diagnostics against the Spike protein from the Novel Coronavirus SARS-Cov-21